Old thyroid drug gets new shot at fighting deadly brain tumors
NCT ID NCT05607407
Summary
This study is testing if methimazole, a drug normally used for thyroid conditions, can help control the growth of glioblastoma, an aggressive brain cancer. Researchers believe the drug might work by boosting the body's natural production of a protective compound called hydrogen sulfide within the tumor. The trial will enroll about 19 adults with progressive glioblastoma to find a safe dose and see if the drug helps delay cancer progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.